marstacimab

Italy

Drugs containing this active substance

  • HYMPAVZI

    It is used to prevent or reduce bleeding in patients aged 12 years and older weighing at least 35 kg who suffer from severe hemophilia A or severe hemophilia B, provided they have not developed factor VIII or IX inhibitors.

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    marstacimab -

    ATC: B02BX11

    Manufacturer: PFIZER EUROPE MA EEIG